Prevalence of the metabolic syndrome in Peruvian Andean hispanics: the PREVENCION study.
暂无分享,去创建一个
R. Goldberg | J. Medina-Lezama | J. Chirinos | J. Chirinos | Fernando F. Corrales-Medina | Humberto Zea-Díaz | Mauricio Postigo-Macdowall | Julio Chirinos-Pacheco | Oscar L. Morey-Vargas | Juan F Bolaños-Salazar | Edgar Muñoz-Atahualpa | Zoila Valdivia-Ascuña | Carolina Cuba-Bustinza | Sheyla Paredes-Díaz | Paola Villalobos-Tapia | Fernando F Corrales-Medina | Josefina Medina-Lezama
[1] P. López-Jaramillo,et al. A proposal for an appropriate central obesity diagnosis in Latin American population. , 2006, International journal of cardiology.
[2] H. Alberti,et al. Prevalence of metabolic abnormalities in the Tunisian adults: a population based study. , 2006, Diabetes & metabolism.
[3] S. Haffner. Risk constellations in patients with the metabolic syndrome: epidemiology, diagnosis, and treatment patterns. , 2006, The American journal of medicine.
[4] D. Rader,et al. Human genetics of variation in high-density lipoprotein cholesterol , 2006, Current atherosclerosis reports.
[5] F. Hu,et al. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. , 2006, Journal of the American College of Cardiology.
[6] S. Haffner,et al. Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects. , 2006, Diabetes care.
[7] J. Medina-Lezama,et al. Design of PREVENCION: a population-based study of cardiovascular disease in Peru. , 2005, International journal of cardiology.
[8] Fernando Costa,et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.
[9] E. Ford. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. , 2005, Diabetes care.
[10] H. Florez,et al. Prevalence and risk factors associated with the metabolic syndrome and dyslipidemia in White, Black, Amerindian and Mixed Hispanics in Zulia State, Venezuela. , 2005, Diabetes research and clinical practice.
[11] J. Medina-Lezama,et al. Cardiovascular disease in Latin America. , 2005, American heart journal.
[12] Rajeev Gupta,et al. Prevalence of metabolic syndrome in an Indian urban population. , 2004, International journal of cardiology.
[13] Ali H Mokdad,et al. Increasing prevalence of the metabolic syndrome among u.s. Adults. , 2004, Diabetes care.
[14] P. Zimmet,et al. Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. , 2004, Diabetes research and clinical practice.
[15] T. Brutsaert,et al. Effects of birthplace and individual genetic admixture on lung volume and exercise phenotypes of Peruvian Quechua. , 2004, American journal of physical anthropology.
[16] C. Morillo,et al. Congestive heart failure in Latin America: the next epidemic. , 2004, American heart journal.
[17] L. Caulfield,et al. Dietary pattern and usual nutrient intakes of Peruvian women during pregnancy , 2003, European Journal of Clinical Nutrition.
[18] B. Ainsworth,et al. International physical activity questionnaire: 12-country reliability and validity. , 2003, Medicine and science in sports and exercise.
[19] F. Azizi,et al. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. , 2003, Diabetes research and clinical practice.
[20] S. Deeb,et al. Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet. , 2003, Journal of lipid research.
[21] P. O'Malley,et al. Validation of the MEDFICTS dietary questionnaire: A clinical tool to assess adherence to American Heart Association dietary fat intake guidelines , 2003, Nutrition journal.
[22] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[23] J. Ruidavets,et al. Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. , 2002, Diabetes care.
[24] Laurent Essioux,et al. Common haplotypes in five genes influence genetic variance of LDL and HDL cholesterol in the general population. , 2002, Human molecular genetics.
[25] S. Deeb,et al. Contribution of Hepatic Lipase, Lipoprotein Lipase, and Cholesteryl Ester Transfer Protein to LDL and HDL Heterogeneity in Healthy Women , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[26] W. Dietz,et al. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.
[27] T F Nelson,et al. Binge drinking and the American college student: what's five drinks? , 2001, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.
[28] L. Groop,et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.
[29] M. Zago,et al. Genetic Diversity in an Andean Population from Peru and Regional Migration Patterns of Amerindians in South America: Data from Y Chromosome and Mitochondrial DNA , 2000, Human Heredity.
[30] R. Mahley,et al. Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase. High density lipoprotein characterization and gender-specific effects of apolipoprotein e genotype. , 2000, Journal of lipid research.
[31] M. Velasco,et al. Hypertension and cardiovascular health in Venezuela and Latin American countries , 2000, Journal of Human Hypertension.
[32] M. Trevisan,et al. Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group. , 1998, American journal of epidemiology.
[33] Stella M. Yu. Healthy People 2010 , 1998, Maternal and Child Health Journal.
[34] S. Yusuf,et al. Emerging Epidemic of Cardiovascular Disease in Developing Countries , 1998 .
[35] S. Oparil,et al. Physical activity and cardiovascular health , 1996 .
[36] P. Williams,et al. Physical activity and public health. , 1995, JAMA.
[37] K. Patrick,et al. Physical Activity and Public Health: A Recommendation From the Centers for Disease Control and Prevention and the American College of Sports Medicine , 1995 .
[38] R. Lozano,et al. [The epidemiological transition in Latin America]. , 1994, Notas de poblacion.
[39] G. Boden,et al. Effects of Age and Body Fat Insulin Resistance in Healthy Men , 1993, Diabetes Care.
[40] H Wechsler,et al. 'Binge' drinkers at Massachusetts colleges. Prevalence, drinking style, time trends, and associated problems. , 1992, JAMA.
[41] S. Haffner,et al. Prospective Analysis of The Insulin-Resistance Syndrome (Syndrome X) , 1992, Diabetes.
[42] R. DeFronzo,et al. Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.
[43] P. Grande,et al. High-density lipoprotein cholesterol assay by magnesium dextransulphate precipitation. , 1986, Scandinavian journal of clinical and laboratory investigation.
[44] J. Rao,et al. Inference From Stratified Samples: Properties of the Linearization, Jackknife and Balanced Repeated Replication Methods , 1981 .
[45] R. Scozzari,et al. Survey of several red cell and serum genetic markers in a Peruvian population. , 1972, American journal of human genetics.
[46] A. Omran. The epidemiologic transition. A theory of the epidemiology of population change. , 1971, The Milbank Memorial Fund quarterly.
[47] A. C. Burton,et al. RECOMMENDATIONS for human blood pressure determinations by sphygmomanometers. , 1967, Journal of the American Medical Association.
[48] Chien-Jen Chen,et al. Prevalence of obesity and metabolic syndrome in Taiwan. , 2006, Journal of the Formosan Medical Association = Taiwan yi zhi.
[49] B. Ainsworth,et al. Guidelines for data processing analysis of the International Physical Activity Questionnaire (IPAQ) - Short and long forms , 2005 .
[50] R. Chávez Domínguez,et al. [Coronary heart disease in Mexico and the clinical epidemiological and preventive relevance]. , 2003, Archivos de cardiologia de Mexico.
[51] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. , 2002, Circulation.
[52] Rafael Lozano,et al. AGE STANDARDIZATION OF RATES: A NEW WHO STANDARD , 2000 .